Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalfampridine in NAION
NCT01975324Phase 4Completed
- Sponsor
- Neuro-Ophthalmologic Associates
- Start
- Jul 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dalfampridine in non-arteritic anterior ischemic optic neuropathy (NAION), sponsored by Neuro-Ophthalmologic Associates. Started Jul 2013; status: completed.
02
Drugs
dalfampridine
03
Conditions
non-arteritic anterior ischemic optic neuropathy (NAION)
Beyond the preview
Go deeper on NCT01975324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01975324.